LMBRD1 Gene Methylmalonic aciduria CblF type Genetic Test
At DNA Labs UAE, we offer the LMBRD1 Gene Methylmalonic aciduria CblF type Genetic Test for individuals who may be affected by this rare genetic disorder. This test helps in diagnosing and managing the condition effectively.
Test Details
The LMBRD1 gene is associated with methylmalonic aciduria CblF type, a rare genetic disorder. This disorder affects the body’s ability to break down certain proteins and fats properly, leading to the accumulation of toxic substances, including methylmalonic acid, in the body.
Our LMBRD1 Gene Methylmalonic aciduria CblF type Genetic Test utilizes NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously. This allows us to identify any mutations or variations in the LMBRD1 gene that may be responsible for the disorder.
Components and Price
The cost of the LMBRD1 Gene Methylmalonic aciduria CblF type Genetic Test is AED 4400.0. The test can be performed using a blood sample, extracted DNA, or even one drop of blood on an FTA Card.
Report Delivery
The report for the LMBRD1 Gene Methylmalonic aciduria CblF type Genetic Test is typically delivered within 3 to 4 weeks from the date of sample submission.
Test Type and Doctor
The LMBRD1 Gene Methylmalonic aciduria CblF type Genetic Test falls under the category of Metabolic Disorders. It is recommended to consult a General Physician for this test.
Test Department
The LMBRD1 Gene Methylmalonic aciduria CblF type Genetic Test is conducted in our Genetics department, where our team of experts ensures accurate and reliable results.
Pre Test Information
Prior to taking the LMBRD1 Gene Methylmalonic aciduria CblF type NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by Methylmalonic aciduria CblF type.
Advantages of NGS Genetic Testing
NGS genetic testing offers several advantages in diagnosing and managing methylmalonic aciduria CblF type. It allows for the simultaneous analysis of multiple genes, providing valuable information for accurate diagnosis and appropriate treatment strategies. NGS genetic testing can also be used for carrier testing in individuals with a family history of the disorder or for prenatal testing in families at risk of having a child with methylmalonic aciduria CblF type.
Choose DNA Labs UAE for reliable and comprehensive genetic testing services. Our NGS technology and expert team ensure accurate results that can make a significant impact on the diagnosis and management of genetic disorders.
| Test Name | LMBRD1 Gene Methylmalonic aciduria CblF type Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for LMBRD1 Gene Methylmalonic aciduria CblF type NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Methylmalonic aciduria CblF type |
| Test Details |
The LMBRD1 gene is associated with a rare genetic disorder called methylmalonic aciduria CblF type. This disorder is characterized by the inability of the body to break down certain proteins and fats properly, leading to the accumulation of toxic substances, including methylmalonic acid, in the body. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify mutations or variations that may be associated with a particular disorder. In the case of methylmalonic aciduria CblF type, NGS genetic testing can be used to identify mutations in the LMBRD1 gene that may be responsible for the disorder. NGS genetic testing involves obtaining a DNA sample from the individual being tested, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology, which allows for the simultaneous analysis of multiple genes. The resulting data is then analyzed to identify any mutations or variations in the LMBRD1 gene that may be causing the disorder. NGS genetic testing can provide valuable information for diagnosing methylmalonic aciduria CblF type and determining the appropriate treatment and management strategies for individuals with this disorder. It can also be used for carrier testing in individuals with a family history of the disorder or for prenatal testing in families at risk of having a child with methylmalonic aciduria CblF type. |
